Reviva Pharmaceuticals Holdings, Inc.
RVPH· OTC
RVPHReviva Pharmaceuticals Holdings, Inc.
Filed Nov 15, 2021 · 10-Q · 46 days after period end · 0001437749-21-026621
| Metric | Q3 2021 | Q3 2019 | Q3 2018 |
|---|---|---|---|
| Net Income | -$2.28M | $136.81K | $263.22K |
| EPS Diluted | -$0.12 | -$0.05 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Reviva Pharmaceuticals Holdings, Inc. · CIK 1742927 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 15, 2021 · 46 d after period end
